Home › LUMINEX CORPORATION › ARIES® MRSA Assay
ARIES® MRSA Assay
LUMINEX CORPORATION · Model 50-10034 · UDI-DI 00840487101445
NQX
Prescription
10
510(k) clearances
56
Adverse events (7 deaths)
20
Recalls
11
Facilities
Description
The ARIES® MRSA Assay is an integrated real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of methicillin–resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-08-06 | Cepheid | As a result of Post-Market half-time stability testing, false negative test result was observed for a positive sample type. |
| 2019-07-17 | Becton Dickinson & Co. | The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly. |
| 2019-07-17 | Becton Dickinson & Co. | The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly. |
| 2019-07-17 | Becton Dickinson & Co. | The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly. |
| 2019-07-17 | Becton Dickinson & Co. | The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly. |
| 2017-10-27 | Roche Molecular Systems, Inc. | The cobas MRSA/SA tests may have decreased performance compared to the analytical sensitivity for MSRA detection. A screening failure can lead to potential infection in the coloni |
| 2016-07-18 | Cepheid | Internal investigation found the certain lots of MRSA kits have the potential for performance issues at lower positive sample concentrations. |
| 2014-07-23 | Becton Dickinson & Co. | The performance of the assay no longer conforms to this statement in the Analytical Specificity section of the Package Insert: One hundred-eleven (111) out of 111 MSSA strains tes |
| 2012-05-22 | Becton Dickinson & Co. | Leakage in Cepheid SmartCycler reaction tubes. |
| 2011-11-17 | Cepheid | Cepheid has received reports from some of its customers regarding higher than desired (>5%) rates of invalid results when using lot numbers 2803 and 3001 of the Xpert MRSA/SA BC (b |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
